4SC reports Phase I data for resminostat in pancreatic and biliary tract cancer

In September, 4SC AG (Xetra:VSC) said partner Yakult Honsha Co. Ltd. (Tokyo:2267) reported data from a Phase I trial in 27 patients with

Read the full 232 word article

User Sign In